My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Trigyn Technologies jumps after contract win by subsidiary
Jan 12,2017

The announcement was made after market hours yesterday, 11 January 2017.

Meanwhile, the S&P BSE Sensex was up 74.29 points or 0.27% at 27,214.70.

On the BSE, 20,686 shares were traded in the counter so far as against average daily volume of 66,260 shares in past one quarter. The stock was locked at a high of Rs 111.50 in intraday trade. The stock had hit a 52-week high of Rs 140.60 on 8 June 2016. The stock had hit a 52-week low of Rs 48.60 on 29 February 2016.

The stock had underperformed the market over the past one month till 11 January 2017, falling 7.33% compared with the Sensex 1.47% gains. The scrip had, however, outperformed the market in past one quarter, rising 0.57% as against Sensexs 3.35% decline.

The small-cap company has equity capital of Rs 29.74 crore. Face value per share is Rs 10.

Trigyn Technologies announced that Trigyn Technologies Inc., a wholly-owned subsidiary of the company awarded Federal GSAs IT Schedule 70 contract.

Trigyn Technologies, Inc. has been awarded a United States General Services Administration (GSA) schedule contract, (GS-35F-139GA), designating Trigyn Technologies, Inc. as an approved vendor on the GSAs IT Schedule 70.

The initial duration of the award is for a period of five years from 19 December 2016 through 18 December 2021. This award enables Government agencies and entities, federal, state and local, to more easily acquire and benefit from Trigyns IT professional services.

Trigyn has been approved to compete as a prime contractor for awards under the Category (SIN) 132-51 - Information Technology Professional Services.

GSAs IT Schedule 70 is the largest and most widely used acquisition vehicle in the Federal Government. The Indefinite Delivery/Indefinite Quantity (IDIQ) Multiple Award Schedule (MAS) provides direct access to products, services and solutions from certified industry partners.

This award will facilitate Trigyns continued expansion of its public sector business, which today encompasses services in more than 15 US states, with a significant presence in the Baltimore - Washington, DC and New York - New Jersey regions.

Trigyn Technologies, Inc. is a Delaware Corporation with offices in Washington, DC, Edison, New Jersey, Toronto, Montreal and Switzerland and development centers in Mumbai, India.

Trigyn Technologies consolidated net profit fell 7.94% to Rs 10.43 crore on 1.81% decline in net sales to Rs 169 crore in Q2 September 2016 over Q1 June 2016.

sTrigyn Technologies is an innovative solutions provider and systems integrator that has been in business for 30 years with more than 1,500 resources deployed today. Trigyn provides IT staffing, consulting, solutions, systems integration, digital marketing and other services to its clients.

Powered by Capital Market - Live News

Prakash Industries gains after receiving mining lease
Jan 12,2017

The announcement was made after market hours yesterday, 11 January 2017.

Meanwhile, the S&P BSE Sensex was up 89.09 points, or 0.33%, to 27,229.50

On the BSE, 4.34 lakh shares were traded on the counter so far as against the average daily volumes of 1.40 lakh shares in the past one quarter. The stock hit a high of Rs 68.90 in intraday trade so far, which is a 52-week high for the counter. The stock had hit a low of Rs 65.50 so far during the day. The stock hit a 52-week low of Rs 23.05 on 12 February 2016.

The stock had outperformed the market over the past 30 days till 11 January 2017, rising 35.22% compared with 1.66% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 15.87% as against Sensexs 1.82% fall.

The small-cap company has equity capital of Rs 135.60 crore. Face value per share is Rs 10.

As per the mining plan, the geological reserves are around 9.9 million tonnes. The mine is expected to be developed in the next 6 months and thereafter the iron ore production from the mine would be utilized for captive purpose, Prakash Industries said. With this captive sourcing, the operating margin and profitability of the company would improve significantly, it added.

Prakash Industries reported 1533.71% surge in net profit to Rs 14.54 crore on 0.69% rise in total income to Rs 502.60 crore in Q2 September 2016 over Q2 September 2015.

Prakash Industries has diversified interests in steel, power and rigid PVC pipes.

Powered by Capital Market - Live News

Steel Strips Wheels gains after winning order
Jan 12,2017

The announcement was made during market hours today, 12 January 2017.

Meanwhile, the S&P BSE Sensex was up 116.51 points or 0.43% at 27,256.92.

On the BSE, 6,101 shares were traded on the counter so far as against the average daily volumes of 9,091 shares in the past one quarter. The stock had hit a high of Rs 710 and a low of Rs 674 so far during the day.

The stock had hit a record high of Rs 775 on 14 October 2016 and a 52-week low of Rs 284 on 17 February 2016.

The small-cap company has equity capital of Rs 15.53 crore. Face value per share is Rs 10.

Steel Strips Wheels (SSWL) announced that it bagged another after-market exports order for supplying caravan steel wheels for European Union (EU) trailer market. Total order covers supplies of 62,000 wheels in 3 months. Orders comprise of 13 inch steel wheels to be supplied by the company with shipments starting from February 2017.

Steel Strips Wheels net profit rose 19.9% to Rs 18.02 crore on 2.8% decline in net sales to Rs 290.95 crore in Q2 September 2016 over Q2 September 2015.

Steel Strips Wheels designs and manufactures automotive steel wheels and is among the leading supplier to Indian and global automobile manufacturers.

Powered by Capital Market - Live News

Hindustan Organic spurts on plans to sell some fixed assets
Jan 12,2017

The announcement was made after market hours yesterday, 11 January 2017.

Meanwhile, the S&P BSE Sensex was up 110.53 points or 0.41% at 27,250.94.

Huge volumes were witnessed on the counter. On the BSE, 4.42 lakh shares were traded in the counter so far as against average daily volume of 77,099 shares in past one quarter. The stock was locked at a high of Rs 25.80 in intraday trade. The stock had hit a low of Rs 24.10 so far during the day. The stock had hit a 52-week high of Rs 27.20 on 26 October 2016. The stock had hit a 52-week low of Rs 12.20 on 17 February 2016.

The stock had outperformed the market over the past one month till 11 January 2017, rising 6.97% compared with the Sensex 1.47% gains. The scrip had also outperformed the market in past one quarter, rising 6.7% as against Sensexs 3.35% decline.

The small-cap company has equity capital of Rs 67.17 crore. Face value per share is Rs 10.

Hindustan Organic Chemicals (HOCL) said that a meeting of the board of directors of the company will be held on 20 January 2017, to consider and to approve the proposal to sell part of the companys land at Rasayani to BPCL.

The board will also consider a proposal to sell land, plant & machinery of C.N.A plant at HOCL Rasayani to The Indian Space Research Organisation (ISRO) as per government of Indias directions.

The board will consider Q3 results on that day.

Hindustan Organic Chemicals reported a net loss of Rs 46 crore in Q2 September 2016, lower than net loss of Rs 48.08 crore in Q2 September 2015. Net sales dropped 0.4% to Rs 26.92 crore in Q2 September 2016 over Q2 September 2015.

Hindustan Organic Chemicals manufactures basic organic chemicals.

Powered by Capital Market - Live News

Biocon scales record high as USFDA accepts BLA for proposed biosimilar Trastuzumab
Jan 12,2017

The announcement was made after market hours yesterday, 11 January 2017.

Meanwhile, the S&P BSE Sensex was up 91.67 points or 0.34% at 27,232.08

On the BSE, 1.64 lakh shares were traded on the counter so far as against the average daily volumes of 32,692 shares in the past one quarter. The stock hit a high of Rs 1,052.05 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 1,017.60 so far during the day. The stock had hit a 52-week low of Rs 430.80 on 12 February 2016.

The stock had outperformed the market over the past 30 days till 11 January 2017, rising 7.2% compared with 1.66% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 6.62% as against Sensexs 1.82% fall.

The large-cap company has equity capital of Rs 100 crore. Face value per share is Rs 5.

Biocon and Mylan N V announced that the US Food and Drug Administration (FDA) has accepted Mylans biologics license application (BLA) for MYL-1401O,a proposed biosimilar trastuzumab, for filing through the 351(k) pathway. This product is a proposed biosimilar to branded trastuzumab,which is indicated to treat certain HER2-positive breast cancers. The anticipated FDA goal date set under the Biosimilar User Fee Act(BsUFA) is 3 September 2017. Mylan and Biocons proposed biosimilar trastuzumab is also under review by the European Medicines Agency (EMA).

Mylan President Rajiv Malik commented that this is Mylan and Biocons first US regulatory submission through the 351(k) pathway and reinforces the strength of collaboration to increase access to a broad portfolio of high-quality, affordable biosimilars worldwide.

Dr Arun Chandavarkar, CEO and Joint Managing Director, Biocon, said it is a major milestone for the Mylan and Biocon collaboration since it is the first US regulatory submission through joint global biosimilars program.

Biocon reported consolidated net profit of Rs 146.70 crore in Q2 September 2016 as compared with net loss of Rs 10.60 crore in Q2 September 2015. Consolidated total income rose 21.3% to Rs 984.20 crore in Q2 September 2016 over Q2 September 2015.

Biocon is Indias largest and fully-integrated, innovation-led biopharmaceutical company.

Powered by Capital Market - Live News

Pharma stocks drop on Trumps rhetoric on drug pricing
Jan 12,2017

Meanwhile, the BSE Sensex was up 84.90 points, or 0.31%, to 27,225.31.

Glenmark Pharmaceuticals (down 1.18%), Aurobindo Pharma (down 2.36%), Cipla (down 0.15%), Dr Reddys Laboratories (down 1.58%), Cadila Healthcare (down 2.13%), Lupin (down 1.27%), Divis Laboratories (down 0.5%), Wockhardt (down 2.25%) and Sun Pharmaceutical Industries (down 1.5%) declined.

The BSE Healthcare index had underperformed the market over the past one month till 11 January 2017, falling 2.71% compared with the Sensex 1.47% gains. The index had also underperformed the market in past one quarter, declining 7.36% as against Sensexs 3.35% decline.

US President-elect Donald Trump said in his first press conference late yesterday, 11 January 2017 that pharmaceutical companies were getting away with murder with respect to drug pricing and promised a complete turnaround, making healthcare less expensive and better.

He said that US is the largest buyer of drugs in the world, and yet, the country does not bid properly, prioritising bringing back drug industries back to the US. He added that US firms would start bidding and save billions.

Trump also said he would repeal and replace Obamacare-the countrys existing affordable healthcare legislation-shortly after price approvals, which could impact pharma companies.

Powered by Capital Market - Live News

Dewan Housing Finance Corporation gains on plan to raise funds
Jan 12,2017

The announcement was made after market hours yesterday, 11 January 2017.

Meanwhile, the S&P BSE Sensex was up 132.89 points or 0.49% at 27,273.30.

On the BSE, 95,000 shares were traded on the counter so far as against the average daily volumes of 2.86 lakh shares in the past one quarter. The stock had hit a high of Rs 273.75 and a low of Rs 268.30 so far during the day.

The stock had hit a record high of Rs 337 on 20 October 2016 and a 52-week low of Rs 140.55 on 12 February 2016.

The mid-cap company has equity capital of Rs 313.13 crore. Face value per share is Rs 10.

Dewan Housing Finance Corporation said that a meeting of the board of directors of the company is scheduled on 16 January 2017, for raising funds by way of issue of preference shares.

Dewan Housing Finance Corporations net profit rose 29% to Rs 232.61 crore on 19.7% rise in operating income to Rs 2167.72 crore in Q2 September 2016 over Q2 September 2015.

Dewan Housing Finance Corporation provides loans for purchase or construction of residential houses.

Powered by Capital Market - Live News

Atlanta gains after winning highway project from NHAI
Jan 12,2017

The announcement was made after market hours yesterday, 11 January 2017.

Meanwhile, the BSE Sensex was up 39.33 points, or 0.14%, to 27,179.74.

On the BSE, 1.97 lakh shares were traded in the counter so far, compared with an average volume of 1.37 lakh shares in the past one quarter. The stock had hit a high of Rs 83.50 and a low of Rs 79.40 so far during the day. The stock had hit a 52-week high of Rs 84.15 on 24 October 2016. The stock had hit a 52-week low of Rs 27.30 on 12 February 2016.

The stock had outperformed the market over the past one month till 11 January 2017, rising 14.71% compared with the Sensex 1.47% gains. The scrip had also outperformed the market in past one quarter, rising 9.83% as against Sensexs 3.35% decline.

The small-cap company has an equity capital of Rs 16.30 crore. Face value per share is Rs 2.

Atlanta said that it has been declared as a preferred bidder by the National Highways Authority of India (NHAI) for six laning of a section of national highway (NH)-8 in Gujarat under National Highways Development Project (NHDP) Phase V (Package-VI) on hybrid annuity mode. The total cost of the project is Rs 1292 crore.

The company will form a special purpose vehicle (SPV) for the implementation of the project.

Net profit of Atlanta jumped 1481.3% to Rs 12.57 crore on 53.3% rise in net sales to Rs 41.15 crore in Q2 September 2016 over Q2 September 2015.

Atlanta is engaged in the business of infrastructure development.

Powered by Capital Market - Live News

Murudeshwar Ceramics gains as board to consider preferential issue of shares
Jan 12,2017

The announcement was made after market hours yesterday, 11 January 2017.

Meanwhile, the S&P BSE Sensex was up 104.66 points, or 0.39%, to 27,245.07

On the BSE, 34,000 shares were traded on the counter so far as against the average daily volumes of 32,692 shares in the past one quarter. The stock had hit a high of Rs 33 and a low of Rs 31.90 so far during the day.

The stock hit a 52-week high of Rs 40.95 on 28 September 2016. The stock hit a 52-week low of Rs 17.70 on 29 February 2016. The stock had outperformed the market over the past 30 days till 11 January 2017, rising 2.35% compared with 1.66% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 13.89% as against Sensexs 1.82% fall.

The small-cap company has equity capital of Rs 40.81 crore. Face value per share is Rs 10.

Murudeshwar Ceramics has steadily progressed to become one of Indian++s largest tile manufacturing company, producing the widest range of products in ceramic and vitrified tiles.

Powered by Capital Market - Live News

NTPC gains as board approves investment for Dulanga coal mining project
Jan 12,2017

The announcement was made after market hours yesterday, 11 January 2017.

Meanwhile, the BSE Sensex was up 44.10 points, or 0.16%, to 27,197.65

On the BSE, 5,885 shares were traded on the counter so far as against the average daily volumes of 2.28 lakh shares in the past one quarter. The stock had hit a high of Rs 165.15 and a low of Rs 164.40 so far during the day.

The stock hit a 52-week high of Rs 169.95 on 19 August 2016. The stock hit a 52-week low of Rs 116.80 on 25 February 2016. The stock had underperformed the market over the past 30 days till 11 January 2017, falling 0.3% compared with 1.66% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 13.89% as against Sensexs 1.82% fall.

The large-cap company has equity capital of Rs 8245.46 crore. Face value per share is Rs 10.

NTPCs net profit declined 17.87% to Rs 2495.97 crore on 8.41% rise in net sales to Rs 19241.47 crore in Q2 September 2016 over Q2 September 2015.

Established in 1975, NTPC is Indias largest power utility with an installed capacity of 48,028 megawatts (MW).

Powered by Capital Market - Live News

Lupin gains after receiving USFDA approval for Desoximetasone Cream
Jan 11,2017

The announcement was made during market hours today, 11 January 2017.

Meanwhile, the S&P BSE Sensex was up 250.62 points or 0.93% at 27,150.18

On the BSE, 1.32 lakh shares were traded on the counter so far as against the average daily volumes of 81,815 shares in the past one quarter. The stock had hit a high of Rs 1,525.90 and a low of Rs 1,491 so far during the day.

The stock had hit a 52-week high of Rs 1,911.55 on 9 February 2016 and a 52-week low of Rs 1,294.05 on 29 March 2016. The stock had underperformed the market over the past 30 days till 10 January 2017, falling 1.01% compared with the Sensexs 1.45% rise. The scrip, however, outperformed the market in past one quarter, sliding 1.89% as against the Sensexs 4.21% fall.

The large-cap company has equity capital of Rs 90.29 crore. Face value per share is Rs 2.

Lupin announced that it has received final approval for its Desoximetasone Cream USP, 0.05% and Desoximetasone Cream USP, 0.25% from the United States Food and Drug Administration (FDA) to market a generic equivalent of Taro Pharmaceuticals North America, Incs Topicort LP Emollient Cream, 0.05% and Taro Pharmaceuticals, Incs (collectively Taro) Topicort Cream, 0.25%.

Desoximetasone Cream USP, 0.05% and Desoximetasone Cream USP, 0.25% are the AB rated generic equivalent of Taros Topicort LP Emollient Cream, 0.05% and Topicort Cream, 0.25%. Both products are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Topicort LP emollient Cream had US sales of $33 million (IMS MAT September 2016) while Topicort Cream had US sales of $17 million (IMS MAT September 2016).

Lupins consolidated net profit rose 57.8% to Rs 662.19 crore on 31.9% rise in net sales to Rs 4211.18 crore in Q2 September 2016 over Q2 September 2015.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-infective and NSAID space and holds global leadership position in the Anti-TB segment.

Powered by Capital Market - Live News

V2 Retail vaults 18.5% in six sessions
Jan 11,2017

Shares of V2 Retail jumped 18.5% in six sessions, to its current ruling price of Rs 135.15, from its close of Rs 114.05 on 3 January 2017.

Meanwhile, the S&P BSE Sensex was up 235.72 points or 0.89% at 27,139.56.

More than usual volumes were seen traded on the counter. On the BSE, 68,727 shares were traded in the counter so far as against average daily volume of 29,479 shares over the past one quarter. The stock had hit a high of Rs 135.15 and a low of Rs 130 so far during the day. The stock had hit a 52-week high of Rs 163.45 on 4 November 2016. The stock had hit a 52-week low of Rs 41.50 on 29 February 2016.

The small-cap company has equity capital of Rs 28.89 crore. Face value per share is Rs 10.

On 7 January 2017, V2 Retail had announced board of directors decision to allot 20.35 lakh shares to Bennett Coleman And Company, other than promoter and/or promoter group pursuant to exercise of option against warrant up to the value of Rs 16.24 crore at a price of Rs 79.85 including premium of Rs 69.85 each.

The board on that day had also accepted resignation of Manshu Tandon, Chief Executive Officer of the company with effect from 31 December 2016.

V2 Retails net profit jumped 657.1% to Rs 1.59 crore on 56.4% rise in net sales to Rs 103.19 crore in Q2 September 2016 over Q2 September 2015.

V2 Retail is one of the fastest growing retail groups in India.

Powered by Capital Market - Live News

Fiberweb India jumps on fund raising plans
Jan 11,2017

The announcement was made during market hours today, 11 January 2017.

Meanwhile, the S&P BSE Sensex was up 246.42 points or 0.88% at 27,136.69.

On the BSE, 41,790 shares were traded in the counter so far as against average daily volume of 72,568 shares in the past one quarter. The stock had hit a high of Rs 184.15 and a low of Rs 171 so far during the day. The stock had hit a record high of Rs 187.05 on 15 December 2016. The stock had hit a 52-week low of Rs 19.85 on 8 February 2016.

The stock had outperformed the market over the past one month till 10 January 2017, gaining 31.59% compared with the Sensexs 0.57% gains. The scrip had also outperformed the market in past one quarter, jumping 49.78% as against the Sensexs 4.21% fall.

The small-cap company has equity capital of Rs 12.60 crore. Face value per share is Rs 10.

Fiberweb Indias net profit jumped 4583.3% to Rs 2.81 crore on 42.4% rise in net sales to Rs 22.06 crore in Q2 September 2016 over Q2 September 2015.

Fiberweb India manufactures high quality spun bond polypropylene non woven roll goods and products which can be used across different sectors,

Powered by Capital Market - Live News

Metal and mining stocks rally
Jan 11,2017

Meanwhile, the S&P BSE Metal index was up 469.27 points or 4.36% at 11,222.43 and was the top performer among the sectoral indices on the BSE.

The Sensex was currently up 228.06 points or 0.85% at 27,133.60. The rise in the S&P BSE Metal index was higher than than Sensexs decline in percentage terms.

Jindal Steel & Power (JSPL) (up 11.62%), Vedanta (up 1.85%), Hindalco Industries (up 6.18%), JSW Steel (up 6.37%), Bhushan Steel (up 5.15%), Tata Steel (up 3.95%), Hindustan Zinc (up 2.26%), Steel Authority of India (Sail) (up 5.3%), National Aluminum Company (up 5.59%), NMDC (up 2.03%), MOIL (up 0.44%) and Hindustan Copper (up 0.89%) rose.

Meanwhile, copper price edged higher in the global commodities markets. High Grade Copper for March 2017 delivery was currently off 0.04% at $2.6115 per pound on the COMEX.

The BSE Metal index index had underperformed the market over the past 30 days till 10 January 2017, falling 1.2% compared with 1.45% rise in the Sensex. The index, however, outperformed the market in past one quarter, gaining 3.29% as against Sensexs 4.21% fall.

Marketmen are awaiting details on Donald Trumps plan for tax cuts and infrastructure spending. Executives from BHP Billiton, the worlds biggest miner, reportedly met with President-elect Donald Trump for talks on the industry, as the incoming administrations pledges to boost infrastructure spending.

Metal stocks across the globe had advanced yesterday, 10 January 2017 after base metal prices jumped due to better-than-expected producer price inflation in China.

Powered by Capital Market - Live News

Welspun India nudges higher after groups investment plans in textile projects
Jan 11,2017

The announcement was made during market hours today, 11 January 2017.

Meanwhile, the BSE Sensex was up 224.68 points, or 0.84%, to 27,124.24.

On the BSE, 42,747 shares were traded in the counter so far, compared with average daily volume of 6.37 lakh shares in the past one quarter. The stock had hit a high of Rs 69.75 and a low of Rs 68.65 so far during the day. The stock had hit a record high of Rs 119.90 on 14 June 2016. The stock had hit a 52-week low of Rs 46.35 on 30 August 2016.

The stock had underperformed the market over the past one month till 10 January 2017, gaining 0.15% compared with the Sensexs 0.57% gains. The scrip had, however, outperformed the market in past one quarter, gaining 21.17% as against the Sensexs 4.21% fall.

The mid-cap company has equity capital of Rs 100.47 crore. Face value per share is Re 1.

Welspun Group, a $2.3 billion global conglomerate operating in home textiles, line pipes and infrastructure announced an investment of Rs 4000 crore for three large textile projects in Gujarat. The three memorandum of understandings (MoUs) which are being signed during the ongoing Vibrant Gujarat Summit 2017 were announced by Mr. BK Goenka - Chairman, Welspun Group at the Summit.

Amongst the larger of the three projects, Welspun will invest Rs 2000 crore in developing an integrated textile manufacturing zone. This will be a part of the Government of Indias Sagarmala project where Kutch is among the first identified key locations.

The company aims to develop a large, modern and futuristic textile industrial complex that will manufacture and supply world class textile products for the global markets. Welspun will leverage on its expertise in developing industrial infrastructures. The Kutch facilitywill provide a unique ecosystem for entrepreneurs to set up manufacturing facilities.

The project will generate direct employment of nearly 5,000 and will provide indirect employment to nearly 15,000 people.

Welspun will further invest Rs 1000 crore in its technical textile business for capacity enhancement, addition of new products and training and skill development. Under this vertical, the company has already made its mark with products for specialised use in healthcare, fire departments and other utilities.

These products include specialised features such as fireretardants, stain resistant, anti-bacterial, PET resistant, and soil resistance, among others. Most of these products are also recyclable. The project will give direct employment to nearly 1,500 people.

Another Rs 1000 crore is being invested in the advanced textile arm of Welspun that focuses on manufacturing specialised materials for applications in aerospace, defense and automobile sectors. The project will generate a direct employment of 2,000 persons and indirect employment of 5,000.

Welspun Group has already invested Rs 10000 crore in Gujarat so far and fresh investments takes total investment to Rs 14000 crore. These investments willfurther consolidate Welspuns global leadership position and explore new avenues for its upcoming businesses in technical as well as advanced textiles.

Welspun India reported consolidated net loss of Rs 147.52 crore in Q2 September 2016 compared with net profit of Rs 179.37 crore in Q2 September 2015. Consolidated net sales rose 18.7% to Rs 1575.71 crore in Q2 September 2016 over Q2 September 2015.

Welspun India is the leading home fashions supplier in the USA and amongst the top 3 global manufacturers of bed and bath linen.

Powered by Capital Market - Live News